Insiders who reported open-market trades in the last 12 months at the companies Donald A. Bergstrom files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Donald A. Bergstrom is a corporate insider, tracked as President, R&D of Relay Therapeutics, Inc. (RLAY). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Donald A. Bergstrom submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Donald A. Bergstrom been buying or selling stock?
Recorded transactions: 0 open-market purchases and 12 open-market sales ($2.48M) across all tracked filings.
Donald A. Bergstrom is President, R&D of Relay Therapeutics, Inc. (RLAY). 11 SEC Form 4 filings on record going back to 2024, most recently on 9 September 2026. Most recent open-market trade: sold $162K of RLAY on 9 September 2026. Lifetime open-market sales: $2.48M.
Recent transactions
13
The latest 13 SEC Form 4 transactions reported by Donald A. Bergstrom.
InsiderAlpha's records for Donald A. Bergstrom go back to 2024: 11 primary Form 4 filings, an average of 3.7 per year. 5 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
